Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel

• Main Authors: Gili Regev-Yochay (Author), Sharon Amit (Author), Moriah Bergwerk (Author), Marc Lipsitch (Author), Eyal Leshem (Author), Rebecca Kahn (Author), Yaniv Lustig (Author), Carmit Cohen (Author), Ram Doolman (Author), Arnona Ziv (Author), Ilya Novikov (Author), Carmit Rubin (Author), Irena Gimpelevich (Author), Amit Huppert (Author), Galia Rahav (Author), Arnon Afek (Author), Yitshak Kreiss (Author)
• Format: Book
• Published: Elsevier, 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Methods: Among all 9650 HCW of a large tertiary...